2017

Late last year, Politico Pro’s Health Care Team, along with CVS Health, held a conversation on the future of prescription drug…

The United States Food and Drug Administration (FDA) was expected to release interchangeability guidance on biosimilars sometime…

In mid-January 2017, the United States Food and Drug Administration (FDA) released a guidance document, entitled “Drug and Device…

The Department of Health and Human Services (HHS), along with fifteen other federal agencies, issued a final rule updating…

Discounts within the health care industry are historically viewed as not being subject to the U.S. Federal Anti-Kick Back Statutes…

The United States Food and Drug Administration (FDA) released a new draft guidance that provides information for medical product…

On January 17, 2017, the Food and Drug Administration (FDA) released a draft guidance intended to assist sponsors in demonstrating…

United States Senators Susan Collins (R-ME) and Claire McCaskill (D-MO), the Chairwoman and Ranking Member of the Senate Aging…

DOJ may have a new focus for Anti-Kickback Statute violations: care facilities and their owners. This year alone, at least two…

We recently had the pleasure of speaking with Michaeline Daboul, President and CEO of MediSpend, about the upcoming administration…